Home HelixNano

HelixNano

In operation
-
Cancer Vaccine Developer
Basic
Enterprise Profile

Basic Information

Helix Nanotechnologies Uses Artificial Intelligence to Help Treat Genetic Diseases. HelixNano is a Y Combinator and venture capital-backed biotechnology startup. At HelixNano, we have been developing cancer vaccines over the past two years. Now, we are adapting our synthetic biology arsenal to address COVID-19. Our next goal is to develop a vaccine that can not only protect everyone from this virus but also safeguard against all future coronaviruses.
HelixNano
Cambridge,Massachusetts,United States of America
less than 15 people
January 01, 2013
info@helixnano.com

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Artificial Intelligence Gene Technology Biotechnology
Concept
Disease Treatment
Application Scenarios
Targeted drugs Innovative Drugs Traditional Vaccines (Biological Products for Prevention) Nucleic Acid Drugs